Cyclophosphamide-induced interstitial pneumonitis in a patient with ovarian carcinoma

Gynecol Oncol. 1984 Jan;17(1):41-51. doi: 10.1016/0090-8258(84)90058-1.

Abstract

A 40-year-old female with ovarian cancer being treated with daily oral cyclophosphamide developed fatal interstitial pneumonitis. Autopsy did not show any evidence of ovarian cancer. The review of the literature revealed eight reported cases of cyclophosphamide-induced interstitial pneumonitis and fibrosis. The case is reported to alert gynecologists to this rare but lethal complication of cyclophosphamide.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cyclophosphamide / adverse effects*
  • Cystadenocarcinoma / complications*
  • Cystadenocarcinoma / drug therapy
  • Cystadenocarcinoma / pathology
  • Female
  • Humans
  • Lung / pathology
  • Ovarian Neoplasms / complications*
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / pathology
  • Pulmonary Fibrosis / chemically induced*
  • Pulmonary Fibrosis / pathology
  • Time Factors

Substances

  • Cyclophosphamide